OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

FUNGAL MENINGITIS STILL KILLING OVER 180,000 PEOPLE EACH YEAR DESPITE DRUGS AVAILABLE TO SAVE LIVES

Posted .

International HIV experts on fungal meningitis in AIDS report finding nearly 250,000 cases annually, 73% in sub-Saharan Africa. Fungal meningitis due to the Cryptococcus fungus typically affects those in the prime of life, 35 years old, and affects the tissues covering the brain and spinal cord. Of those affected an estimated 181,000 people die, despite… Read more »

Read more >

Burden of fungal diseases in Belarus, Cameroon, Indonesia and Italy presented at ECCMID Vienna

Posted .

For the fourth year running, multiple country burdens of fungal diseases have been presented at ECCMID; 4 countries covering a population of 351 million people. The remarkable findings were: The annual incidence of candidaemia in Italy is 24/100,000 and was estimated at 5/100,000 for Belarus, Cameroon and Indonesia, in the absence of data. Cryptococcal meningitis… Read more »

Read more >

Ruling by World Health Organisation delights Doctors

Posted .

Itraconazole, voriconazole and natamycin 5% ophthalmic preparation ruled as ‘essential antifungals’  GAFFI (Global Action Fund for Fungal Infections) says today’s announcement that three drugs capable of reducing deaths in hundreds of thousands of people worldwide have been given essential medicines status is a Red Letter Day in the fight to reduce blindness and save lives…. Read more »

Read more >

Fight back against fungal infections started in Lagos today

Posted .

At the Lagos University Teaching Hospital, a high level course on fungal diseases started today. With over 17 million Nigerians affected by serious fungal infections, and tens of thousands of deaths, better diagnostics are the cornerstone of improved care. The course focuses on modern diagnostics that need to be incorporated into routine care in Nigeria…. Read more »

Read more >

Delivering on Antimicrobial Resistance Agenda (AMR) Not Possible without Improving Fungal Diagnostic Capabilities

Posted .

Ignorance of fungal disease and lack of diagnostics across the world is causing doctors to unknowingly overprescribe antibiotics a new report warns. Experts from GAFFI (the Global Action Fund for Fungal Infections) caution that we will lose the battle against antibiotic resistance unless doctors better understand how to suspect fungal disease and have proper access… Read more »

Read more >

GAFFI opens UK sister foundation and Oddi Aasheim joins as Director

Posted .

For operational and fund raising reasons, GAFFI has set up a sister foundation in the form of a Charitable Incorporated Organisation – GAFFI UK. Sharing identical objectives and the same website, GAFFI UK will enable GAFFI to begin to implement its programs more easily and at less cost, and become tax-efficient for UK tax payers…. Read more »

Read more >

Itraconazole, voriconazole and natamycin 5% ophthalmic preparation proposed as WHO ‘essential antifungal medicines’

Posted .

GAFFI has applied for itraconazole (capsules and oral suspension), voriconazole (capsules and intravenous solution) and natamycin 5% ophthalmic solution to be placed on the World Health Organization (WHO) Essential Medicine List (EML), in collaboration with colleagues from the Instituto de Salud Carlos III, International Foundation for Dermatology, London School of Hygiene of Tropical Medicine and… Read more »

Read more >